XML 137 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
Pre-tax income (loss) consisted of the following for the years ended December 31:
 
2019
 
2018
(as restated)
 
2017
Domestic 1
$
4,777

 
$
23,092

 
$
(2,940
)
Foreign
16,779

 
26,484

 
15,738

Total
$
21,556

 
$
49,576

 
$
12,798


(1) The Company has adjusted certain prior period amounts for the restatement and immaterial corrections of error. See Note 2 for details.
A reconciliation of income taxes computed at the statutory rates to the reported income tax provision for the years ended December 31 follows:
 
2019
 
2018
(as restated)
 
2017
Federal provision at statutory rate 1
$
4,527

 
$
10,411

 
$
4,480

U.S./Foreign tax rate differential
393

 
731

 
(919
)
Foreign non-deductible expenses
2,059

 
(1,759
)
 
(2,006
)
Foreign tax provision
793

 
1,253

 
615

State taxes, net of federal benefit 1
308

 
619

 
49

State tax rate change, net of federal benefit
(41
)
 
(32
)
 
(264
)
Change in uncertain tax positions
15

 
84

 
119

Change in valuation allowance
(2,054
)
 
597

 
2,475

Tax credits
(2,652
)
 
(2,049
)
 
(152
)
Share-based compensation
(14
)
 
(50
)
 
(657
)
Change in U.S. corporate tax rate

 

 
7,277

Repatriation of foreign earnings
1,235

 
(3,670
)
 
3,964

GILTI, net of related foreign tax credit
730

 
1,194

 

Other
479

 
758

 
86

Provision for income taxes
$
5,778

 
$
8,087

 
$
15,067


(1) The Company has adjusted certain prior period amounts for the restatement and immaterial corrections of error. See Note 2 for details.
The provision (benefit) for income taxes for the years ended December 31 follows:
 
2019
 
2018 (as restated)
 
2017
 
Current
 
Deferred
 
Total
 
Current
 
Deferred
 
Total
 
Current
 
Deferred
 
Total
Federal 1
$
(205
)
 
$
(336
)
 
$
(541
)
 
$
(3,432
)
 
$
4,426

 
$
994

 
$
2,954

 
$
7,446

 
$
10,400

State and local 1
214

 
883

 
1,097

 
123

 
87

 
210

 
362

 
(384
)
 
(22
)
Foreign
4,207

 
1,015

 
5,222

 
6,365

 
518

 
6,883

 
4,042

 
647

 
4,689

Total
$
4,216

 
$
1,562

 
$
5,778

 
$
3,056

 
$
5,031

 
$
8,087

 
$
7,358

 
$
7,709

 
$
15,067


(1) The Company has adjusted certain prior period amounts for the restatement and immaterial corrections of error. See Note 2 for details.










A summary of deferred income tax assets and liabilities as of December 31 follows:
 
2019
 
2018
(as restated)
Noncurrent deferred tax assets: 1
 
 
 
Amortization and fixed assets
$
1,457

 
$
1,992

Accounts receivable
129

 
166

Inventories
2,032

 
2,226

Pension obligations
2,134

 
2,375

Warranty obligations
741

 
827

Accrued benefits
369

 
382

Foreign exchange contracts
91

 
(367
)
Restricted stock
126

 
106

Operating leases
165

 

Tax credit carryforwards
3,843

 
3,537

Net operating loss carryforwards
12,657

 
16,817

Other temporary differences not currently available for tax purposes
2,902

 
2,945

Total noncurrent deferred tax assets
$
26,646

 
$
31,006

Valuation allowance
(11,992
)
 
(14,665
)
Net noncurrent deferred tax assets
$
14,654

 
$
16,341

Noncurrent deferred tax liabilities:
 
 
 
Amortization and fixed assets
$
(2,501
)
 
$
(2,960
)
Accounts receivable
72

 
54

Inventories
115

 
123

Warranty obligations
1

 
1

Accrued benefits
(111
)
 
67

Operating leases
27

 

Net operating loss carryforwards
1,517

 
2,272

Other temporary differences not currently available for tax purposes
(678
)
 
(351
)
Total noncurrent tax liabilities
(1,558
)
 
(794
)
Total net deferred tax asset
$
13,096

 
$
15,547


(1) The Company has adjusted certain prior period amounts for the restatement and immaterial corrections of error. See Note 2 for details.
We assess whether valuation allowances should be established against deferred tax assets based on consideration of all available evidence using a “more likely than not” standard. This assessment considers, among other matters, the nature, frequency and severity of recent losses, forecasts of future profitability, the duration of statutory carryforward periods, our experience with unused tax attributes expiring and tax planning alternatives. In making such judgments, significant weight is given to evidence that can be objectively verified.
During 2019, we recorded additional valuation allowance of $0.7 million on the deferred tax assets of our United Kingdom subsidiary and certain U.S. state tax net operating loss carryforwards, and released $3.4 million in valuation allowances related to the deferred tax assets of our Luxembourg subsidiaries. We expect to be able to realize the benefits of all of our deferred tax assets that are not currently offset by a valuation allowance, as discussed above. In the event that our actual results differ from our estimates or we adjust these estimates in future periods, the effects of these adjustments could materially impact our financial position and results of operations.
As of December 31, 2019, the Company had net operating loss carryforwards of $115.2 million, of which $55.2 million related to foreign jurisdictions and $60.0 million related to U.S. state jurisdictions. The carryforward periods for these net operating losses range from five years to indefinite. Utilization of these losses is subject to the tax laws of the applicable tax jurisdiction and may be limited by the ability of certain subsidiaries to generate taxable income in the associated tax jurisdiction. We have established valuation allowances for all net operating losses that we believe are more likely than not to expire before they can be utilized.
As of December 31, 2019, we had $2.5 million of U.S. foreign tax credits carried forward primarily attributable to the deemed repatriation of the accumulated untaxed earnings of our foreign subsidiaries resulting from the U.S. Tax Reform. Utilization of these credits may be limited if the Company does not continue to generate U.S. federal taxable income in future years. The credits begin to expire in 2027.
As of December 31, 2019, we had $1.3 million of research and development tax credits being carried forward related to our U.S. operations. Utilization of these credits may be limited if the Company does not continue to generate U.S. federal taxable income in future years. As a result of the Tax Cuts and Jobs Act of 2017, the unutilized research and development tax credits the Company generated after December 31, 2017 can be carried forward indefinitely whereas the credits generated prior to that date are subject to a 20-year carryforward period. Approximately $0.5 million of the Company's tax credits are subject to the 20-year carryforward period and begin to expire between between 2025 and 2039.
As of December 31, 2019, cash of $39.5 million was held by foreign subsidiaries. During the year ended December 31, 2019, $19.4 million, net of $1.0 million in foreign withholding tax incurred, was repatriated from the Company's foreign subsidiaries. The Company plans to repatriate an additional $12.0 million in 2020 and a $0.8 million deferred tax liability was recorded during the year ended December 31, 2019 for the expected future income tax implications.
We file federal income tax returns in the U.S. and income tax returns in various states and foreign jurisdictions. In the U.S., we are generally no longer subject to tax assessment for tax years prior to 2016. In our major non-U.S. jurisdictions including China, Czech Republic, Mexico and the United Kingdom, tax years are typically subject to examination for three to five years.
As of December 31, 2019, and 2018, we provided a liability of $0.9 million for unrecognized tax benefits related to U.S. federal and state, and foreign jurisdictions. The majority of these unrecognized tax benefits are netted against their related noncurrent deferred tax assets.
We accrue interest and penalties related to unrecognized tax benefits through income tax expense. We had $0.4 million and $0.3 million accrued for the payment of interest and penalties as of December 31, 2019 and December 31, 2018, respectively. Accrued interest and penalties are included in the $0.9 million of unrecognized tax benefits.
A reconciliation of the beginning and ending amount of unrecognized tax benefits (including interest and penalties) at December 31 follows:
 
2019
 
2018
(as restated)
 
2017
Balance - Beginning of the year 1
$
894

 
$
811

 
$
1,098

Gross increase - tax positions in prior periods 1
70

 
66

 
70

Gross decreases - tax positions in prior periods 1
(39
)
 
(14
)
 
(219
)
Gross increases - current period tax positions 1

 
59

 
65

Lapse of statute of limitations
(12
)
 
(12
)
 
(221
)
Currency translation adjustment
(5
)
 
(16
)
 
18

Balance - End of the year 1
$
908

 
$
894

 
$
811


(1) The Company has adjusted certain prior period amounts for the restatement and immaterial corrections of error. See Note 2 for details.